285
Participants
Start Date
May 2, 2018
Primary Completion Date
January 14, 2020
Study Completion Date
February 14, 2020
5mg Serlopitant Tablets
Serlopitant Tablets
Placebo Tablets
Placebo Tablets
Study Site 500, New York
Study Site 517, New York
Study Site 507, Brooklyn
Study Site 508, Buffalo
Study Site 522, Pittsburgh
Study Site 523, Philadelphia
Study Site 525, Glenn Dale
Study Site 532, Morgantown
Study Site 341, High Point
Study Site 510, Newnan
Study Site 210, Coral Gables
Study Site 531, Miami
Study Site 222, North Miami Beach
Study Site 530, Miami
Study Site 501, Aventura
Study Site 534, Fort Lauderdale
Study Site 504, Birmingham
Study Site 805, Nashville
Study Site 511, Knoxville
Study Site 228, Louisville
Study Site 524, Dublin
Study Site 516, Bexley
Study Site 509, Cleveland
Study Site 506, Ann Arbor
Study Site 515, Detroit
Study Site 388, Skokie
Study Site 528, St Louis
Study Site 371, Saint Joseph
Study Site 227, Omaha
Study Site 527, New Orleans
Study Site 533, Rogers
Study Site 112, Tulsa
Study Site 502, Dallas
Study Site 224, Houston
Study Site 520, Bellaire
Study Site 226, Webster
Study Site 361, San Antonio
Study Site 359, Pflugerville
Study Site 365, Austin
Study Site 526, Henderson
Study Site 383, North Hollywood
Study Site 356, San Diego
Study Site 514, Santa Ana
Study Site 204, Fremont
Study Site 806, Spokane
Study Site 379, Boston
Study Site 201, East Windsor
Study Site 529, Verona
Study Site 345, Johnston
Vyne Therapeutics Inc.
INDUSTRY